近日，FDA批准了Quinnova制药公司的新产品—Neosalus软膏。这是Neosalus泡沫制剂的一个延伸产品，该药局部使用，是首个可用于治疗多种皮肤疾病（包括异位性皮炎和手部湿疹）的非甾体类抗炎处方泡沫制剂。
Neosalus膏剂和泡沫制剂均采用了Quinnova公司Proderm独家专利技术，可促进皮肤的修复、保护和保湿。
除了疗效比较理想，患者使用这两种剂型的药物之后，可同时享受到采用Pderm技术化妆品的效果，常用的膏剂和乳液产品通常令人感觉使用部位比较油腻，而Neosalus以其独特的配方，能使药物易于涂抹，皮肤对药物快速吸收，并且无油腻感。
Quinnova公司负责人表示，要对顽固性皮肤病如异位性皮炎和手部湿疹等进行治疗，需要制定长期综合的治疗方案，因为在用药过程中需要在缓解炎症的同时克服皮肤屏障。Neosalus软膏剂面世后，为患者提供了更多的治疗选择。
Neosalus (emollients topical)
NEOSALUS CREAM
NEOSALUS LOTION
NEOSALUS Rx
Add Drug To My List Compare to related Drugs View/edit/Compare drugs in my list
Select the drug indication to add to your list
NEOSALUS
Pruritus and dry skin  Only 4 drugs may be compared at once

Generic Name and Formulations:
Dimethicone, ethylparaben, glycerin, methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, stearic acid, trolamine, butane and propane (propellants); foam; fragrance-free.
Company:
Quinnova Pharmaceuticals

Select therapeutic use: Pruritus and dry skin
Indications for NEOSALUS:
Dermatitis (eg, atopic dermatitis, contact dermatitis).

Adults and Children:
Apply to affected areas 3 times daily or as needed.

Warnings/Precautions:
Avoid contact with eyes, lips, angles of the nose, and mucous membranes. Discontinue if sensitivity or irritation occurs. Avoid exposure to sun or UV light.

Pharmacological Class:
Antipruritic (nonsteroidal).

Adverse Reactions:
Erythema, dryness, scaling, burning, pruritus.

How Supplied:
Foam—10g, 70g, 200g; Crm—60g, 100g; Lotion—236mL